SynerGenetics Bioscience
Vancouver
About SynerGenetics Bioscience
SynerGenetics Bioscience Inc. is a Canadian plant genetics research and development company focused on developing high-yield CBD hemp strains/seeds. The Company is led by a management team with combined 35+ years of cannabis/hemp industry experience and a clear vision of capitalizing on the growing hemp and CBD markets. SG’s R&D team successfully utilized proprietary technology to identify desirable plant traits to create hemp strains yielding 12%+ CBD content to address commercial hemp farming problems. With yields averaging less than 7% on many strains used by hemp farmers, the 5% difference is material – both financially and quality wise.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.0M
- Funding stage: Seed
- Last round: Seed (Mar 2020)
- Website: sgbioscience.com
- Phone: +1 604 249 2143
Industries & Categories
Biotechnology, Genetics, Product Research
Social Profiles
Canonical: https://fsome.com/organization/synergenetics-bioscience-121275 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.